Press "Enter" to skip to content

New patent expiration for Merck Sharp drug CLARINEX-D 12 HOUR

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Merck Sharp drug CLARINEX-D 12 HOUR

Annual Drug Patent Expirations for CLARINEX-D+12+HOUR
Annual Drug Patent Expirations for CLARINEX-D+12+HOUR

Clarinex-d 12 Hour is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

This drug has fifty-seven patent family members in thirty-seven countries.

The generic ingredient in CLARINEX-D 12 HOUR is desloratadine; pseudoephedrine sulfate. One supplier is listed for this compound. Additional details are available on the desloratadine; pseudoephedrine sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Merck Sharp drug CLARINEX-D 12 HOUR
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions